The effectiveness and side effects of dexamethasone in preterm infants with bronchopulmonary dysplasia.
Open Access
- 1 March 1993
- journal article
- research article
- Published by BMJ in Archives of Disease in Childhood
- Vol. 68 (3 Spec No) , 330-336
- https://doi.org/10.1136/adc.68.3_spec_no.330
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Changes in the plasma aminogram of parenterally fed infants treated with dexamethasone for bronchopulmonary dysplasia.Archives of Disease in Childhood, 1992
- Tumour necrosis factor in the bronchoalveolar secretions of infants with the respiratory distress syndrome and the effect of dexamethasone treatment.Thorax, 1992
- Catabolic effect of dexamethasone in the preterm baby.Archives of Disease in Childhood, 1992
- Renal calcification after dexamethasone in infants with bronchopulmonary dysplasiaThe Lancet, 1991
- Adrenal response in very low birthweight babies after dexamethasone treatment for bronchopulmonary dysplasia.Archives of Disease in Childhood, 1989
- A Controlled Trial of Dexamethasone in Preterm Infants at High Risk for Bronchopulmonary DysplasiaNew England Journal of Medicine, 1989
- Dexamethasone in bronchopulmonary dysplasia.Archives of Disease in Childhood, 1988
- Effects of antenatal dexamethasone administration in the infant: Long-term follow-upThe Journal of Pediatrics, 1984
- Relative immunosuppressive potency of various corticosteroids measured in vitroEuropean Journal of Clinical Pharmacology, 1983
- Corticosteroids block binding of chemotactic peptide to its receptor on granulocytes and cause disaggregation of granulocyte aggregates in vitro.Journal of Clinical Investigation, 1981